加载中
NASDAQFinancial ServicesShell Companies
最新数据
US$10.75
−US$0.01 · -0.09%
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
前收盘价
US$10.75
−US$0.01 · -0.09%
盘中时间采用ET。市场数据可能有所延迟。
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
日内区间
当前US$10.75
52周区间
当前US$10.75
盘中时间采用ET。市场数据可能有所延迟。
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
日内区间
当前US$10.75
52周区间
当前US$10.75
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 |
|---|---|---|
| 销售、一般及管理费用 | 119.57万 USD | 703.61 USD |
| 营业费用 | 119.57万 USD | 703.61 USD |
| 利息收入 | 848.45万 USD | 158.87万 USD |
| 折旧和摊销 | — | 70.36万 USD |
| 营业利润 | −119.57万 USD | −703 USD |
| 净利润 | 728.88万 USD | 2663 USD |
公司数据更新于 2026年10月11日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
